Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › KY › LEXINGTON › SAINT JOSEPH HEALTH SYSTEM, INC

SAINT JOSEPH HEALTH SYSTEM, INC

NPI: 1447457775 · LEXINGTON, KY 40509 · General Acute Care Hospital · NPI assigned 06/29/2007

$67.41M
Total Medicaid Paid
1,142,880
Total Claims
859,823
Beneficiaries
358
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMCINTOSH, KIMBERLY (BUSINESS OFFICE MANAGER)
Parent OrganizationSAINT JOSEPH HEALTH SYSTEM, INC
NPI Enumeration Date06/29/2007

Related Entities

Other providers sharing the same authorized official: MCINTOSH, KIMBERLY

ProviderCityStateTotal Paid
SAINT JOSEPH HEALTH SYSTEM, INC LEXINGTON KY $85.54M
SAINT JOSEPH HEALTH SYSTEM INC MARTIN KY $1.90M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 194,205 $10.68M
2019 180,380 $9.70M
2020 187,009 $9.78M
2021 180,400 $11.08M
2022 147,504 $9.45M
2023 144,235 $9.24M
2024 109,147 $7.47M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 31,362 23,838 $11.35M
99283 Emergency department visit for the evaluation and management, moderate severity 38,796 33,110 $9.57M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 11,548 8,432 $4.86M
74177 Computed tomography, abdomen and pelvis; with contrast material 6,771 5,750 $3.66M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 43,101 36,149 $1.87M
99282 Emergency department visit for the evaluation and management, low to moderate severity 13,193 11,730 $1.82M
74176 Computed tomography, abdomen and pelvis; without contrast material 3,500 2,936 $1.62M
G0378 Hospital observation service, per hour 9,847 6,072 $1.40M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 16,659 5,580 $1.23M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 23,955 18,129 $1.04M
70450 Computed tomography, head or brain; without contrast material 4,606 3,852 $1.03M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 19,492 15,337 $962K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2,901 2,223 $961K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2,203 1,856 $864K
96375 Therapeutic injection; each additional sequential IV push 21,383 14,515 $861K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 22,210 15,166 $859K
0202U Oncology (prostate), multianalyte, gene expression profiling 3,639 3,247 $829K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 6,091 2,822 $761K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 11,462 6,496 $744K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1,723 1,537 $658K
58662 630 406 $648K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 11,792 8,127 $622K
80053 Comprehensive metabolic panel 47,522 37,258 $581K
71045 Radiologic examination, chest; single view 12,199 9,978 $573K
76830 Ultrasound, transvaginal 2,379 2,191 $538K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 7,780 3,118 $524K
71275 Computed tomographic angiography, chest, with contrast material 1,442 1,218 $497K
95810 Polysomnography; sleep staging with 4 or more additional parameters 710 639 $495K
72125 Computed tomography, cervical spine; without contrast material 1,407 1,235 $493K
59025 Fetal non-stress test 5,457 3,542 $460K
71046 Radiologic examination, chest; 2 views 7,362 6,282 $453K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 636 424 $417K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 13,792 7,902 $415K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 52,233 40,348 $387K
76705 Ultrasound, abdominal, real time with image documentation; limited 1,476 1,314 $380K
96361 Intravenous infusion, hydration; each additional hour 14,892 9,196 $355K
36415 Collection of venous blood by venipuncture 70,806 43,620 $345K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 663 541 $298K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 2,737 2,479 $276K
72131 782 685 $273K
73630 3,540 3,192 $270K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 4,898 2,601 $243K
58558 201 184 $237K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 11,739 10,038 $235K
73130 2,984 2,647 $230K
93458 367 120 $224K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2,739 2,259 $218K
73030 2,594 2,209 $209K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 5,310 4,669 $203K
71260 Computed tomography, thorax, diagnostic; with contrast material 722 565 $201K
76642 2,502 2,264 $199K
70551 Magnetic resonance imaging, brain; without contrast material 590 525 $193K
73610 2,485 2,205 $190K
72100 2,061 1,795 $188K
77067 Screening mammography, bilateral, including computer-aided detection 3,921 3,743 $177K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 361 335 $166K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,328 1,178 $160K
96376 5,419 3,550 $159K
96367 4,297 1,500 $158K
83880 5,389 4,291 $150K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 2,274 1,851 $132K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 4,672 4,305 $129K
93971 981 847 $126K
84484 11,320 8,754 $123K
C1776 Joint device (implantable) 134 59 $122K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 1,281 1,133 $117K
84703 14,134 12,230 $117K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 375 331 $114K
73560 1,474 1,280 $113K
87507 343 300 $112K
0240U 1,742 1,542 $108K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 264 187 $107K
95811 143 135 $105K
73110 1,510 1,290 $103K
93017 337 296 $101K
62323 745 453 $98K
74240 645 562 $97K
84443 Thyroid stimulating hormone (TSH) 5,985 5,169 $91K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 3,030 1,994 $90K
83970 2,579 2,383 $88K
97162 1,551 1,242 $87K
47562 46 42 $86K
J2704 Injection, propofol, 10 mg 13,154 10,448 $86K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2,930 2,638 $85K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,904 2,623 $84K
74018 1,503 1,334 $83K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 5,364 2,569 $83K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3,594 3,225 $83K
73562 966 858 $83K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 1,491 1,194 $81K
C1769 Guide wire 1,264 677 $78K
77063 Screening digital breast tomosynthesis, bilateral 4,505 3,913 $72K
81001 24,818 21,143 $72K
J7030 Infusion, normal saline solution , 1000 cc 17,167 13,342 $71K
84702 5,420 4,646 $70K
80048 Basic metabolic panel (calcium, ionized) 7,854 5,981 $70K
83690 11,975 10,353 $68K
96116 670 473 $67K
97161 1,580 1,075 $64K
83735 10,814 8,997 $64K
77065 Tomosynthesis, mammo 1,707 1,442 $60K
64493 494 268 $60K
83605 6,404 5,203 $59K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,845 1,879 $59K
J0696 Injection, ceftriaxone sodium, per 250 mg 5,668 4,606 $57K
87086 Culture, bacterial; quantitative colony count, urine 8,422 7,226 $56K
96415 1,087 722 $56K
82728 4,373 3,936 $54K
87486 1,528 1,378 $54K
80076 3,731 2,433 $54K
84145 2,515 2,193 $53K
96136 810 704 $53K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1,551 1,399 $53K
82947 10,816 5,585 $52K
72040 671 561 $52K
73564 780 690 $50K
J2795 Injection, ropivacaine hydrochloride, 1 mg 2,904 2,310 $50K
96137 820 713 $49K
77066 Tomosynthesis, mammo 1,434 1,190 $48K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 171 89 $47K
99152 1,355 929 $45K
83921 2,536 2,371 $43K
87040 3,708 2,210 $41K
J3010 Injection, fentanyl citrate, 0.1 mg 12,914 8,536 $41K
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 1,766 1,005 $40K
85027 6,764 5,720 $39K
99281 Emergency department visit for the evaluation and management, self-limited or minor 410 361 $39K
97535 Self-care/home management training, each 15 minutes 1,348 916 $38K
80061 Lipid panel 3,320 2,607 $38K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 13,480 10,379 $38K
95806 195 176 $37K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 1,407 494 $37K
73502 686 594 $35K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 82 78 $34K
87581 1,522 1,377 $33K
J7050 Infusion, normal saline solution, 250 cc 5,104 2,907 $33K
90715 1,141 1,062 $32K
82330 2,143 1,479 $32K
82565 3,557 2,303 $32K
85610 7,809 6,396 $31K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,577 1,372 $31K
71250 172 118 $31K
82747 2,102 1,950 $31K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 928 850 $30K
88307 223 159 $30K
81025 4,223 3,671 $28K
73080 372 336 $28K
83036 Hemoglobin; glycosylated (A1C) 3,684 3,218 $28K
84112 394 338 $27K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,663 1,604 $27K
J0694 Injection, cefoxitin sodium, 1 gm 2,025 1,524 $27K
85730 5,878 4,932 $26K
97530 Therapeutic activities, direct patient contact, each 15 minutes 645 441 $26K
64494 102 95 $26K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 3,944 1,761 $26K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 668 412 $26K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation 169 148 $26K
96132 432 374 $25K
84439 1,834 1,470 $25K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 934 183 $25K
J2469 Injection, palonosetron hcl, 25 mcg 148 66 $25K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 204 168 $24K
J1170 Injection, hydromorphone, up to 4 mg 7,153 4,978 $24K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,632 2,072 $24K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1,018 930 $24K
45380 Colonoscopy, flexible; with biopsy, single or multiple 41 38 $23K
83540 4,267 3,910 $23K
76770 136 125 $23K
85379 2,722 2,426 $22K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 425 359 $22K
88304 401 377 $22K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 1,947 1,492 $22K
12001 135 121 $22K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 3,088 2,486 $21K
42820 Tonsillectomy and adenoidectomy; younger than age 12 32 30 $21K
87081 3,172 2,843 $21K
J1885 Injection, ketorolac tromethamine, per 15 mg 10,514 8,523 $21K
94761 279 203 $20K
J2405 Injection, ondansetron hydrochloride, per 1 mg 21,620 16,148 $19K
J7120 Ringers lactate infusion, up to 1000 cc 4,982 4,161 $19K
81003 8,032 7,035 $19K
70486 66 61 $18K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 321 265 $18K
87186 1,929 1,722 $18K
86140 3,930 3,333 $17K
J0690 Injection, cefazolin sodium, 500 mg 2,845 2,075 $17K
C1762 Connective tissue, human (includes fascia lata) 16 12 $16K
86850 2,254 1,770 $16K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 221 189 $15K
36591 597 345 $15K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 5,273 2,380 $14K
84520 2,011 1,454 $14K
76536 108 88 $14K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1,073 1,001 $13K
84436 2,381 2,105 $13K
85014 1,234 793 $13K
J2270 Injection, morphine sulfate, up to 10 mg 5,881 4,408 $13K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 88 82 $13K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 9,913 7,884 $13K
83550 1,624 1,456 $12K
87077 1,211 1,078 $12K
10060 88 83 $12K
84132 2,240 1,624 $11K
87088 1,354 1,218 $11K
64635 54 40 $11K
J0171 Injection, adrenalin, epinephrine, 0.1 mg 708 562 $11K
A4213 Syringe, sterile, 20 cc or greater, each 1,298 982 $10K
74022 122 114 $10K
82435 1,943 1,393 $10K
84295 1,944 1,394 $10K
87070 1,951 1,044 $10K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 375 303 $10K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 57 51 $10K
82550 1,702 1,431 $10K
J1200 Injection, diphenhydramine hcl, up to 50 mg 4,951 3,250 $9K
J2550 Injection, promethazine hcl, up to 50 mg 5,187 3,823 $9K
A9577 Injection, gadobenate dimeglumine (multihance), per ml 148 113 $9K
97116 356 193 $9K
J3475 Injection, magnesium sulfate, per 500 mg 1,994 1,433 $9K
72141 26 25 $9K
J1644 Injection, heparin sodium, per 1000 units 2,723 1,260 $9K
86900 3,254 2,683 $9K
82607 645 565 $9K
80050 General health panel 283 221 $9K
86901 3,263 2,691 $8K
77080 94 80 $8K
77061 357 293 $8K
96417 268 148 $8K
73120 99 82 $8K
83615 1,468 1,189 $7K
77062 290 229 $7K
J2060 Injection, lorazepam, 2 mg 1,816 1,426 $7K
85049 375 296 $7K
72202 91 80 $7K
J1040 Injection, methylprednisolone acetate, 80 mg 598 527 $7K
64636 61 39 $7K
80320 129 104 $7K
73090 85 81 $7K
85652 2,496 2,160 $7K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 105 97 $6K
J2250 Injection, midazolam hydrochloride, per 1 mg 5,973 4,597 $6K
82803 305 253 $6K
64450 122 85 $6K
80047 204 156 $6K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 172 79 $6K
72070 87 73 $6K
88312 135 123 $5K
87210 1,249 848 $5K
82784 32 12 $5K
84550 1,278 1,037 $5K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 22 19 $5K
J3411 Injection, thiamine hcl, 100 mg 1,019 701 $5K
J2785 Injection, regadenoson, 0.1 mg 28 25 $5K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 206 172 $5K
J3490 Unclassified drugs 1,007 305 $4K
70498 15 13 $4K
C9113 Injection, pantoprazole sodium, per vial 916 634 $4K
73590 59 55 $4K
72128 15 12 $4K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 537 482 $4K
87205 949 822 $4K
J3370 Injection, vancomycin hcl, 500 mg 369 224 $4K
20610 25 16 $4K
96102 43 29 $4K
J1815 Injection, insulin, per 5 units 1,051 158 $3K
84207 149 141 $3K
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 500 447 $3K
A9575 Injection, gadoterate meglumine, 0.1 ml 80 66 $3K
80074 94 73 $3K
94760 266 153 $3K
87807 236 218 $3K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 1,795 1,309 $3K
J1630 Injection, haloperidol, up to 5 mg 686 557 $3K
82948 530 352 $3K
87641 97 88 $3K
82731 45 36 $3K
84425 151 144 $3K
82985 198 182 $3K
J1030 Injection, methylprednisolone acetate, 40 mg 261 230 $3K
99406 154 130 $2K
99153 Mod sedat endo service >5yrs 120 88 $2K
29125 27 25 $2K
82746 201 188 $2K
73522 27 25 $2K
76775 18 15 $2K
76870 13 13 $2K
80179 189 165 $2K
J1596 Injection, glycopyrrolate, 0.1 mg 222 192 $2K
84100 454 328 $2K
36416 341 292 $2K
82378 114 87 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg 1,440 1,161 $2K
90688 129 104 $2K
94729 36 28 $2K
96368 118 68 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 23 20 $2K
72110 13 12 $2K
80323 14 12 $2K
76000 30 26 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 643 548 $1K
Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg 15 13 $1K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 77 41 $1K
G0008 Administration of influenza virus vaccine 107 87 $1K
J8540 Dexamethasone, oral, 0.25 mg 376 343 $1K
71101 33 24 $1K
97035 58 12 $1K
93880 14 12 $1K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring 13 12 $1K
12011 12 12 $1K
81257 14 13 $1K
J7060 5% dextrose/water (500 ml = 1 unit) 343 207 $1K
82533 50 39 $971.69
J0735 Injection, clonidine hydrochloride, 1 mg 716 581 $952.62
73140 13 13 $867.31
J1650 Injection, enoxaparin sodium, 10 mg 118 51 $863.51
J1626 Injection, granisetron hydrochloride, 100 mcg 99 71 $857.68
80143 59 54 $814.70
J2919 Injection, methylprednisolone sodium succinate, 5 mg 133 99 $807.10
73060 12 12 $784.97
84460 171 132 $782.36
82150 141 123 $778.74
84450 168 131 $757.64
94664 128 113 $730.27
84134 68 63 $670.76
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 603 515 $654.39
94060 17 12 $649.65
J0330 Injection, succinylcholine chloride, up to 20 mg 61 55 $648.47
Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 396 206 $644.29
90837 Psychotherapy, 53 minutes with patient 14 13 $601.57
J0360 Injection, hydralazine hcl, up to 20 mg 50 36 $507.36
82140 28 24 $443.55
J1453 Injection, fosaprepitant, 1 mg 18 12 $431.38
96523 38 37 $365.79
86308 44 39 $318.31
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 15 12 $301.88
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 13 12 $244.40
81015 496 432 $236.14
J1956 Injection, levofloxacin, 250 mg 31 25 $226.72
J2003 Injection, lidocaine hydrochloride, 1 mg 218 180 $215.19
82570 95 81 $207.42
J0780 Injection, prochlorperazine, up to 10 mg 27 24 $197.38
87075 17 15 $171.91
J1171 Injection, hydromorphone, 0.1 mg 62 43 $148.99
85018 129 77 $131.33
J0595 Injection, butorphanol tartrate, 1 mg 47 40 $130.45
J7510 Prednisolone oral, per 5 mg 97 95 $122.86
J3105 Injection, terbutaline sulfate, up to 1 mg 42 37 $117.53
84156 60 51 $97.63
J3360 Injection, diazepam, up to 5 mg 12 12 $86.08
J2470 Injection, pantoprazole sodium, 40 mg 14 13 $81.27
J3480 Injection, potassium chloride, per 2 meq 25 14 $68.10
82374 34 24 $29.72
82962 34 24 $26.61
J2370 Injection, phenylephrine hcl, up to 1 ml 15 12 $7.16
J2305 Injection, nitroglycerin, 5 mg 17 13 $2.46
Q0239 Injection, bamlanivimab-xxxx, 700 mg 13 12 $0.24
Q0244 Injection, casirivimab and imdevimab, 1200 mg 34 34 $0.00
A9270 Non-covered item or service 901 155 $0.00